181 related articles for article (PubMed ID: 29894468)
41. Targeting CD24 for treatment of ovarian cancer by short hairpin RNA.
Su D; Deng H; Zhao X; Zhang X; Chen L; Chen X; Li Z; Bai Y; Wang Y; Zhong Q; Yi T; Qian Z; Wei Y
Cytotherapy; 2009; 11(5):642-52. PubMed ID: 19593703
[TBL] [Abstract][Full Text] [Related]
42. EFEMP1 promotes ovarian cancer cell growth, invasion and metastasis via activated the AKT pathway.
Yin X; Fang S; Wang M; Wang Q; Fang R; Chen J
Oncotarget; 2016 Jul; 7(30):47938-47953. PubMed ID: 27351229
[TBL] [Abstract][Full Text] [Related]
43. Inhibition of Ovarian Epithelial Carcinoma Tumorigenesis and Progression by microRNA 106b Mediated through the RhoC Pathway.
Chen S; Chen X; Xiu YL; Sun KX; Zhao Y
PLoS One; 2015; 10(5):e0125714. PubMed ID: 25933027
[TBL] [Abstract][Full Text] [Related]
44. Targeting HMGB1 inhibits ovarian cancer growth and metastasis by lentivirus-mediated RNA interference.
Chen J; Liu X; Zhang J; Zhao Y
J Cell Physiol; 2012 Nov; 227(11):3629-38. PubMed ID: 22331597
[TBL] [Abstract][Full Text] [Related]
45. Lentivirus-mediated shRNA interference of clusterin blocks proliferation, motility, invasion and cell cycle in the ovarian cancer cells.
Fu Y; Lai Y; Liu J; Liu X; You Z; Yang G
J Ovarian Res; 2015 Aug; 8():59. PubMed ID: 26293319
[TBL] [Abstract][Full Text] [Related]
46. Long Noncoding RNA MNX1-AS1 Knockdown Inhibits Cell Proliferation and Migration in Ovarian Cancer.
Lv Y; Li H; Li F; Liu P; Zhao X
Cancer Biother Radiopharm; 2017 Apr; 32(3):91-99. PubMed ID: 28414551
[TBL] [Abstract][Full Text] [Related]
47. Slug Is Associated With Tumor Metastasis and Angiogenesis in Ovarian Cancer.
Gu A; Jie Y; Yao Q; Zhang Y; Mingyan E
Reprod Sci; 2017 Feb; 24(2):291-299. PubMed ID: 27368877
[TBL] [Abstract][Full Text] [Related]
48. HSDL2 Acts as a Promoter in Pancreatic Cancer by Regulating Cell Proliferation and Lipid Metabolism.
Han A; Xu R; Liu Y; Yin X; Lin Z; Yang W
Onco Targets Ther; 2021; 14():435-444. PubMed ID: 33488098
[TBL] [Abstract][Full Text] [Related]
49. Ectopic expression of HSDL2 is related to cell proliferation and prognosis in breast cancer.
Dong B; Yang Y; Han A; Zhang S; Lin Z; Wang Y; Piao J
Cancer Manag Res; 2019; 11():6531-6542. PubMed ID: 31372054
[TBL] [Abstract][Full Text] [Related]
50. γ-Glutamyl cyclotransferase contributes to tumor progression in high grade serous ovarian cancer by regulating epithelial-mesenchymal transition via activating PI3K/AKT/mTOR pathway.
Li Y; Wu T; Wang Y; Yang L; Hu C; Chen L; Wu S
Gynecol Oncol; 2018 Apr; 149(1):163-172. PubMed ID: 29429592
[TBL] [Abstract][Full Text] [Related]
51. Knockdown of Nucleostemin in an ovarian cancer SKOV-3 cell line and its effects on cell malignancy.
Wang J; Wang L; Ji Q; Zhu H; Han S
Biochem Biophys Res Commun; 2017 May; 487(2):262-267. PubMed ID: 28412352
[TBL] [Abstract][Full Text] [Related]
52. MiR-760 overexpression promotes proliferation in ovarian cancer by downregulation of PHLPP2 expression.
Liao Y; Deng Y; Liu J; Ye Z; You Z; Yao S; He S
Gynecol Oncol; 2016 Dec; 143(3):655-663. PubMed ID: 27726922
[TBL] [Abstract][Full Text] [Related]
53. Knockdown of eIF4E suppresses cell proliferation, invasion and enhances cisplatin cytotoxicity in human ovarian cancer cells.
Wan J; Shi F; Xu Z; Zhao M
Int J Oncol; 2015 Dec; 47(6):2217-25. PubMed ID: 26498997
[TBL] [Abstract][Full Text] [Related]
54. Lentivirus-mediated knockdown of Krüppel-like factor 9 inhibits the growth of ovarian cancer.
Zhang QH; Dou HT; Tang YJ; Su S; Liu PS
Arch Gynecol Obstet; 2015 Feb; 291(2):377-82. PubMed ID: 25216959
[TBL] [Abstract][Full Text] [Related]
55. Overexpression of Pyruvate Kinase Type M2 (PKM2) Promotes Ovarian Cancer Cell Growth and Survival Via Regulation of Cell Cycle Progression Related with Upregulated CCND1 and Downregulated CDKN1A Expression.
Zheng B; Liu F; Zeng L; Geng L; Ouyang X; Wang K; Huang Q
Med Sci Monit; 2018 May; 24():3103-3112. PubMed ID: 29752805
[TBL] [Abstract][Full Text] [Related]
56. CKAP2 Promotes Ovarian Cancer Proliferation and Tumorigenesis Through the FAK-ERK Pathway.
Zhang M; Zhao L
DNA Cell Biol; 2017 Nov; 36(11):983-990. PubMed ID: 28933561
[TBL] [Abstract][Full Text] [Related]
57. Reduced Klotho expression contributes to poor survival rates in human patients with ovarian cancer, and overexpression of Klotho inhibits the progression of ovarian cancer partly via the inhibition of systemic inflammation in nude mice.
Yan Y; Wang Y; Xiong Y; Lin X; Zhou P; Chen Z
Mol Med Rep; 2017 Apr; 15(4):1777-1785. PubMed ID: 28259911
[TBL] [Abstract][Full Text] [Related]
58. Prognostic and therapeutic value of disruptor of telomeric silencing-1-like (DOT1L) expression in patients with ovarian cancer.
Zhang X; Liu D; Li M; Cao C; Wan D; Xi B; Li W; Tan J; Wang J; Wu Z; Ma D; Gao Q
J Hematol Oncol; 2017 Jan; 10(1):29. PubMed ID: 28114995
[TBL] [Abstract][Full Text] [Related]
59. Lentivirus-Mediated RNAi silencing targeting ERCC1 reverses cisplatin resistance in cisplatin-resistant ovarian carcinoma cell line.
Du P; Zhang X; Liu H; Chen L
DNA Cell Biol; 2015 Jul; 34(7):497-502. PubMed ID: 25941922
[TBL] [Abstract][Full Text] [Related]
60. MiR-31 is an independent prognostic factor and functions as an oncomir in cervical cancer via targeting ARID1A.
Wang N; Zhou Y; Zheng L; Li H
Gynecol Oncol; 2014 Jul; 134(1):129-37. PubMed ID: 24793973
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
